Santa Monica, CA4 Active Studies

Multiple Myeloma Clinical Trials in Santa Monica, CA

Find 4 actively recruiting multiple myeloma clinical trials in Santa Monica, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
2,720
Enrolling

Recruiting Multiple Myeloma Studies in Santa Monica

RecruitingSanta Monica, CANCT06208150

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

The purpose of this study is to compare the effectiveness of either talquetamab plus pomalidomide (Tal-P) or talquetamab plus teclistamab (Tal-Tec) with elotuzumab, pomalidomide, and dexamethasone (EP...

795 participants
Janssen Research & Development, LLC
View Study Details
RecruitingSanta Monica, CANCT05317416

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

The purpose of this study is to evaluate whether elranatamab monotherapy can provide clinical benefit compared to lenalidomide monotherapy (control) in participants with newly diagnosed multiple myelo...

760 participants
Pfizer
View Study Details
RecruitingSanta Monica, CANCT04638647

Secukinumab Open Label Roll-over Extension Protocol

The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment w...

715 participants
Novartis Pharmaceuticals
View Study Details
RecruitingSanta Monica, CANCT06413498

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have receiv...

450 participants
Kite, A Gilead Company
View Study Details

About Multiple Myeloma Clinical Trials in Santa Monica

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 4 multiple myeloma clinical trials recruiting participants in Santa Monica, CA. These studies are seeking a combined 2,720 participants. Research is being sponsored by Janssen Research & Development, LLC, Pfizer, Novartis Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Santa Monica — FAQ

Are there multiple myeloma clinical trials in Santa Monica?

Yes, there are 4 multiple myeloma clinical trials currently recruiting in Santa Monica, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Monica?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.

Are clinical trials in Santa Monica free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 4 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated March 2, 2026 from ClinicalTrials.gov